| --- | --- | --- | --- | |-------|------------------------------|-------|-------| | | | | | | | | | | | | CHEMED CORPORA | | Z | | | | | | | | | | | | | Results as of March 31, 2021 | | | | | | | B | | | He | | are | Safe Harbor and Regulation G Statement This presentation contains information about Chemed's EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted Diluted EPS, which are not measures derived in accordance with GAAP and which exclude components that are important to und ...

| --- | --- | |-------|------------------------------------| | | | | (IRS | Employer Identification No.) 45202 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2021 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as speci ...

Chemed Corporation (NYSE:CHE) Q1 2021 Earnings Conference Call March 28, 2021 10:30 AM ET Company Participants Sherri Warner – Investor Relations Kevin McNamara – President and Chief Executive Officer Dave Williams – Executive Vice President and Chief Financial Officer Nick Westfall – President and Chief Executive Officer-Chemed's VITAS Healthcare Corporation subsidiary Conference Call Participants Joanna Gajuk – Bank of America Frank Morgan – RBC Capital Markets Operator Good morning. Thank you for standin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from ________ to________ Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati ...

Chemed Corporation (NYSE:CHE) Q4 2020 Earnings Conference Call February 24, 2021 10:00 AM ET Company Participants Sherri Warner – Investor Relations Kevin McNamara – President and Chief Executive Officer Dave Williams – Executive Vice President and Chief Financial Officer Nick Westfall – President and Chief Executive Officer-VITAS Healthcare Corporation Conference Call Participants Frank Morgan – RBC Capital Markets Joanna Gajuk – Bank of America Operator Ladies and gentlemen, thank you for standing by, and ...

45202 (Zipcode) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or org ...

Chemed Corporation (NYSE:CHE) Q3 2020 Results Conference Call October 30, 2020 10:00 AM ET Company Participants Sherri Warner - Director of IR Kevin McNamara - President & CEO David Williams - EVP & CFO Nick Westfall - Presdient & CEO VITAS Healthcare Corporation Conference Call Participants Joanna Gajuk - Bank of America Frank Morgan - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by, and welcome to the Chemed Corporation Third Quarter 2020 Earnings Conference Call. At this tim ...

| --- | --- | --- | |----------------------------------|-------|-------| | | | | | | | | | | | | | CHEMED CORPORATION | | | | | | | | | | | | Results as of September 30, 2020 | | | | | | | | | | care | Safe Harbor and Regulation G Statement This presentation contains information about Chemed's EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted Diluted EPS, which are not measures derived in accordance with GAAP and which exclude components that are important to understanding Cheme ...

Chemed Corporation (NYSE:CHE) Q2 2020 Earnings Conference Call July 30, 2020 10:00 AM ET Company Participants Sherri Warner - Investor Relations Kevin McNamara - President & Chief Executive Officer David Williams - Executive Vice President & Chief Financial Officer Nicholas Westfall - Executive Vice President, Chief Executive Officer & Chief Operating Officer, VITAS Healthcare Corporation Conference Call Participants Bradley Bowers - Bank of America Merrill Lynch Frank Morgan - RBC Capital Markets Operator ...

| --- | --- | |------------|---------------------| | | | | Employer | Identification No.) | | 45202 (Zip | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified ...